|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 2643322 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11791401.0 |
| Date of filing the European patent application | 2011-11-21 | |
| (97) | Date of publication of the European application | 2013-10-02 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-30 |
| (46) | Date of publication of the claims translation | 2018-01-10 |
| (86) | Number | PCT/US2011/061678 |
| Date | 2011-11-21 |
| (87) | Number | WO 2012/071336 |
| Date | 2012-05-31 |
| (30) | Number | Date | Country code |
| 416656 P | 2010-11-23 | US |
| (72) |
CATRON, Nathaniel D., US
CHEN, Shuang, US
GONG, Yuchuan, US
ZHANG, Geoff G., US
|
| (73) |
Abbvie Inc.,
1 North Waukegan Road, North Chicago, IL 60064,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Apoptozę skatinančio agento druskos ir kristalinės formos |
| SALTS AND CRYSTALLINE FORMS OF AN APOPTOSIS-INDUCING AGENT |
| Payment date | Validity (years) | Amount | |
| 2018-11-09 | 8 | 185.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2019-07-14 |